Quantcast
Tag archive for ‘Basilea Pharmaceutica’
By Guest Author On Wednesday, April 5th, 2017
0 Comments

GlaxoSmithKline Urges Third Circuit to Ignore Ruling in Fosamax Case

GlaxoSmithKline PLC has asked the Third Circuit Appeals Court to ignore the ruling in a product liability case involving the drug Fosamax when deciding whether to revive a suit brought on by buyers of Wellbutrin. More...

By Robert Herriman On Friday, February 28th, 2014
0 Comments

Swiss pharma company, Basilea, receives FDA Qualified Infectious Disease Product designation for fungal drug, isavuconazole

PRESS RELEASE Basilea Pharmaceutica Ltd. announced Thursday that the U.S. Food and Drug Administration (FDA) designated isavuconazole as a Qualified Infectious Disease Product (QIDP) for the treatment of invasive More...


Recent Posts

December 6, 2019, Comments Off on

December 6, 2019, Comments Off on

December 4, 2019, Comments Off on

December 4, 2019, Comments Off on

DISPATCH BLOGS

Splash Page logo 300x146 Today in History